7 JCI-accredited hospitals · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Medical Condition

Antiphospholipid Syndrome

Antiphospholipid Syndrome is an autoimmune clotting disorder. Learn symptoms, causes, diagnosis, treatment options and pregnancy care.

RheumatologyICD-10: D68.61
Overview — Antiphospholipid Syndrome
Condition at a Glance
ICD-10 codeD68.61
SpecialtyRheumatology
Specialists5 doctors available

Quick answer

Antiphospholipid syndrome is an autoimmune disorder in which abnormal antibodies increase the risk of blood clots and pregnancy-related complications. Diagnosis is based on medical history, blood tests, and assessment of clotting events, and treatment in Turkey typically focuses on reducing clot risk and protecting pregnancy with individualized use of blood-thinning and supportive therapies.

What is antiphospholipid syndrome?

Antiphospholipid syndrome, sometimes shortened to APS, is an autoimmune condition. Autoimmune means that the body’s immune system, which normally protects against infection, mistakenly produces antibodies (defensive proteins) that attack the body’s own tissues. In antiphospholipid syndrome, these antibodies are directed against phospholipids, which are fat molecules found in the outer layer of cells, and against certain proteins that bind to them. The result is blood that clots more easily than it should.

Because of this tendency toward abnormal clotting, people with antiphospholipid syndrome are at higher risk of blood clots forming in veins (such as deep vein thrombosis, a clot in a deep leg vein) and in arteries (which can cause stroke or heart attack). The condition is also an important cause of pregnancy complications, including repeated miscarriage.

Antiphospholipid syndrome can occur on its own, which doctors call primary APS, or it can occur alongside another autoimmune disease, most often systemic lupus erythematosus (lupus), in which case it is called secondary APS. The condition is diagnosed more often in women than in men, and it is frequently identified in young and middle-aged adults, sometimes after a pregnancy loss or an unexpected blood clot. However, it can affect people of any age, including, rarely, children.

Understanding what is antiphospholipid syndrome and how it behaves is the first step toward managing it. With appropriate treatment and follow-up, many people with the condition live full, active lives, although it usually requires long-term medical care.

Symptoms of antiphospholipid syndrome

Antiphospholipid syndrome symptoms vary widely from person to person. Some people carry the antibodies for years without any problems, while others experience serious clotting events. Importantly, the antibodies themselves do not cause symptoms; symptoms appear when a clot forms or when pregnancy is affected.

Common signs and symptoms may include:

  • Deep vein thrombosis (DVT): pain, swelling, warmth, or redness in one leg, caused by a clot in a deep vein.
  • Pulmonary embolism: sudden shortness of breath, chest pain, or coughing up blood, caused by a clot that travels to the lungs.
  • Stroke or transient ischemic attack (TIA, a “mini-stroke”): sudden weakness or numbness on one side of the body, slurred speech, facial drooping, or vision changes, sometimes in relatively young people.
  • Pregnancy complications: repeated miscarriages (especially after the tenth week of pregnancy), stillbirth, premature birth, or preeclampsia (dangerously high blood pressure in pregnancy).
  • Livedo reticularis: a lace-like, purplish, mottled pattern on the skin, often on the legs.
  • Low platelet count (thrombocytopenia): platelets are the blood cells that help clotting; a low count can cause easy bruising or, less often, bleeding.
  • Headaches or migraines: some people report frequent or severe headaches.
  • Heart valve problems: the antibodies can sometimes thicken or damage heart valves, which may cause a murmur or, over time, symptoms such as breathlessness.

Symptoms can differ depending on where clots form and on the type of the condition. In secondary APS, symptoms of the underlying autoimmune disease, such as joint pain, rashes, or fatigue from lupus, may also be present. A rare but very serious form called catastrophic antiphospholipid syndrome (CAPS) involves clots forming in many small blood vessels at once over days, which can damage several organs rapidly. CAPS is a medical emergency, but it affects only a small minority of people with the condition.

Because clotting events can be sudden and serious, it is important to recognize the warning signs listed in the final section of this article and to seek urgent care when they appear.

Causes and risk factors

The exact antiphospholipid syndrome causes are not fully understood. What is known is that the immune system produces abnormal antibodies, commonly called antiphospholipid antibodies, which interfere with the normal balance of clotting in the blood. The three antibodies most often tested for are lupus anticoagulant, anticardiolipin antibodies, and anti-beta-2 glycoprotein I antibodies. Despite its name, lupus anticoagulant does not require having lupus and, confusingly, promotes clotting in the body rather than preventing it.

Why some people develop these antibodies is still being studied. Several factors appear to play a role:

  • Other autoimmune diseases: antiphospholipid syndrome occurs more often in people who have lupus or, less commonly, other autoimmune conditions.
  • Genetics: the condition is not directly inherited, but a family history of autoimmune disease may slightly increase the likelihood of developing it.
  • Infections: certain viral or bacterial infections can trigger temporary antiphospholipid antibodies; these are often short-lived and do not always cause disease.
  • Medications: in some cases, certain drugs have been associated with the appearance of these antibodies.

It is also important to distinguish between having the antibodies and having the syndrome. Some people test positive for antiphospholipid antibodies but never develop clots or pregnancy complications. In these people, additional risk factors can raise the chance that a clot will eventually form, including:

  • Smoking
  • Estrogen-containing contraceptives or hormone replacement therapy
  • Pregnancy and the weeks after delivery
  • Prolonged immobility, such as long flights, surgery, or bed rest
  • High blood pressure, high cholesterol, obesity, or diabetes
  • Other clotting disorders

Managing these additional risk factors is an important part of care, because they add to the clotting risk created by the antibodies themselves.

Diagnosis

Antiphospholipid syndrome diagnosis is based on a combination of clinical events and laboratory tests. Doctors generally do not diagnose the condition from blood tests alone; there must also be a history of a clotting event or specific pregnancy complications.

The main steps usually include:

  • Medical history and examination: your doctor will ask about previous blood clots, strokes, miscarriages or other pregnancy problems, autoimmune conditions, and family history.
  • Blood tests for antiphospholipid antibodies: laboratories test for lupus anticoagulant, anticardiolipin antibodies, and anti-beta-2 glycoprotein I antibodies. Because these antibodies can appear temporarily after infections, a positive result is usually confirmed with a second test at least twelve weeks later. Persistent positivity on two occasions is a key requirement for diagnosis.
  • Imaging tests: if a clot is suspected, doctors may use ultrasound (sound-wave imaging, often used for leg vein clots), computed tomography (CT) scans, or magnetic resonance imaging (MRI) to confirm the location and extent of a clot, or to assess a stroke.
  • Other blood tests: a complete blood count can detect low platelets, and additional tests may look for related autoimmune diseases such as lupus.

Doctors often refer to internationally recognized classification criteria, which combine at least one clinical event (a confirmed clot or defined pregnancy complication) with persistently positive antibody tests. Interpreting these tests can be complicated, particularly because some blood-thinning medications can affect the results, so testing is usually planned and interpreted by specialists such as rheumatologists (doctors specializing in autoimmune and joint diseases) or hematologists (doctors specializing in blood disorders). In many hospital systems, including Acibadem, the rheumatology department typically coordinates the diagnostic evaluation, often working together with hematology and obstetrics when needed.

Treatment options for antiphospholipid syndrome

There is currently no cure that removes the antibodies permanently, so antiphospholipid syndrome treatment focuses on preventing blood clots and protecting pregnancies. The right approach depends on whether you have already had a clot, whether you are pregnant or planning pregnancy, and your overall clotting risk.

Observation and risk-factor management

People who have antiphospholipid antibodies but have never had a clot or pregnancy complication may not need strong blood thinners. In many cases, doctors recommend careful monitoring combined with reducing other clotting risks: not smoking, maintaining a healthy weight, staying active, controlling blood pressure and cholesterol, and avoiding estrogen-containing contraceptives where possible. Some doctors may recommend low-dose aspirin in selected people, based on individual risk.

Anticoagulant medication (blood thinners)

For people who have had a blood clot, the standard treatment is anticoagulation, meaning medication that reduces the blood’s ability to clot. Options often include:

  • Warfarin: a long-established oral blood thinner. It requires regular blood tests (called INR tests) to make sure the dose keeps the blood within a safe target range. For many people with antiphospholipid syndrome who have had clots, long-term or indefinite warfarin is recommended.
  • Heparin and low-molecular-weight heparin: injectable blood thinners, often used when a clot is first diagnosed, around surgery, or during pregnancy, because warfarin can harm a developing baby.
  • Low-dose aspirin: sometimes used together with other treatments, particularly in pregnancy or for people with arterial clot risk, depending on the individual situation.

Newer oral blood thinners, known as direct oral anticoagulants, are generally not recommended for many people with antiphospholipid syndrome, especially those with the highest-risk antibody profiles, because studies have raised concerns that they may be less effective than warfarin in this condition. Your doctor will discuss which medication is appropriate for you.

Treatment in pregnancy

Women with antiphospholipid syndrome who are pregnant or planning pregnancy usually receive a combination of low-dose aspirin and injectable heparin, tailored to their history. This approach has substantially improved the chances of a successful pregnancy for many women, although close monitoring by both an obstetrician experienced in high-risk pregnancies and a specialist in the syndrome remains essential.

Treatment of severe disease

Catastrophic antiphospholipid syndrome, the rare form with widespread clotting, is treated urgently in the hospital, typically with a combination of anticoagulation, corticosteroids (anti-inflammatory hormones), and treatments that remove or block the harmful antibodies, such as plasma exchange (a procedure that filters the blood) or intravenous immunoglobulin. In secondary APS, treating the underlying autoimmune disease is also part of care.

Surgery is not a treatment for the syndrome itself, although people with the condition need careful planning of their blood thinners before and after any operation to balance clotting and bleeding risks. Long-term management is usually coordinated by specialists in autoimmune disease; you can read more about this specialty at the Rheumatology Department page.

Living with antiphospholipid syndrome and outlook

For many people, antiphospholipid syndrome is a manageable long-term condition rather than a constantly active illness. With consistent anticoagulation and regular follow-up, the risk of new clots can be substantially reduced, although it cannot be eliminated entirely. The outlook varies: some people have a single clotting event and remain stable for years on treatment, while others experience recurrent problems and need more intensive management. Honest, ongoing communication with your care team helps tailor treatment as your circumstances change.

Day-to-day life with the condition often involves a few practical adjustments:

  • Taking medication reliably: blood thinners work only when taken consistently. If you take warfarin, keeping up with INR blood tests is important.
  • Being mindful of bleeding risk: blood thinners increase the chance of bleeding. Tell every healthcare provider, including dentists, that you take them, and seek advice before taking new medications, including over-the-counter painkillers.
  • Watching your diet on warfarin: large changes in intake of vitamin K-rich foods (such as leafy greens) can affect warfarin; consistency matters more than avoidance, and your doctor or pharmacist can advise you.
  • Reducing other risks: avoiding smoking, staying active, moving regularly on long journeys, and managing blood pressure and cholesterol all help.
  • Planning pregnancy in advance: if you may become pregnant, discuss this with your doctors early, because medications often need to be adjusted before conception.

Living with a chronic clotting disorder can also be emotionally demanding, particularly after a frightening event such as a stroke or a pregnancy loss. Support from family, patient organizations, and mental health professionals can be a valuable part of overall care.

Frequently asked questions

What is antiphospholipid syndrome in simple terms?

It is an autoimmune condition in which the immune system makes antibodies that cause the blood to clot too easily. These clots can form in veins or arteries and can also interfere with pregnancy. It is diagnosed through a combination of a clotting or pregnancy event and repeated positive blood tests for specific antibodies.

Can antiphospholipid syndrome be cured?

At present there is no cure that permanently removes the antibodies. However, the condition can usually be managed effectively with blood-thinning medication and risk-factor control, allowing many people to prevent further clots and live active lives. Research into new treatments is ongoing.

How serious is antiphospholipid syndrome?

Seriousness varies considerably. Untreated, the condition can cause dangerous clots, including stroke and pulmonary embolism, and it is a recognized cause of pregnancy loss. With appropriate treatment and follow-up, the risk of these events is significantly reduced for many people. The rare catastrophic form is life-threatening but affects only a small minority of patients.

What are the first antiphospholipid syndrome symptoms people notice?

There are often no symptoms until a clot forms. The condition is frequently discovered after a deep vein thrombosis, a pulmonary embolism, a stroke in a younger person, or repeated miscarriages. Some people notice a lace-like purplish skin pattern, frequent headaches, or easy bruising before diagnosis, although these signs are not specific to the syndrome.

Can I have a healthy pregnancy with antiphospholipid syndrome?

Many women with the condition go on to have successful pregnancies, particularly when treatment with low-dose aspirin and heparin injections is started early and the pregnancy is closely monitored by an experienced team. Pregnancy in this condition is considered higher risk, so planning ahead with your doctors before conceiving is strongly encouraged.

Will I need blood thinners for the rest of my life?

If you have had a clot related to antiphospholipid syndrome, doctors often recommend long-term, sometimes indefinite, anticoagulation because the risk of another clot remains elevated. If you have the antibodies but have never had a clot, lifelong blood thinners are not always necessary. The decision is individual and should be reviewed periodically with your specialist.

Is antiphospholipid syndrome the same as lupus?

No. They are separate conditions, although they often occur together. When antiphospholipid syndrome occurs alongside lupus it is called secondary APS. One of the antibody tests is named “lupus anticoagulant,” which causes confusion, but a positive result does not mean you have lupus.

When to see a doctor

If you have been diagnosed with antiphospholipid syndrome, or you carry antiphospholipid antibodies, contact your doctor promptly if you develop new or unexplained symptoms, if you become pregnant, or before starting any new medication that could interact with blood thinners. Routine follow-up visits and blood tests should not be skipped, even when you feel well.

Seek emergency medical care immediately if you experience any of the following red-flag symptoms:

  • Sudden weakness or numbness on one side of the body, facial drooping, difficulty speaking, or sudden vision loss (possible stroke)
  • Sudden shortness of breath, sharp chest pain, rapid heartbeat, or coughing up blood (possible pulmonary embolism)
  • Chest pain or pressure that spreads to the arm, neck, or jaw (possible heart attack)
  • New pain, swelling, warmth, or redness in one leg (possible deep vein thrombosis)
  • Severe or unusual headache, confusion, or seizures
  • Heavy or uncontrollable bleeding, blood in urine or stool, or vomiting blood, especially while taking blood thinners
  • In pregnancy: severe headache, visual disturbances, sudden swelling, severe abdominal pain, or reduced movement of the baby

These symptoms can indicate a clot, a bleed, or a pregnancy emergency, all of which require urgent assessment. Acting quickly can make a significant difference to the outcome, so do not wait to see whether symptoms pass on their own.

Add Acıbadem on Google

Add us as a Preferred Source to see more of our trusted health content across Google Search, AI Overviews and Discover.

Share this page

Medically reviewed by the Acıbadem International Medical Board — September 2, 2026
See our medical review board →

Published: June 8, 2026Last updated: September 2, 2026
Update history
  • PublishedJune 8, 2026
  • Medical review approvedSeptember 2, 2026
  • Last content updateSeptember 2, 2026
Departments

Care at Acibadem

Specialists

Doctors Who Treat This Condition

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.